Who was FDA’s worst lawyer?
Executive Summary
The Food and Drug Law Institute's recent conference on Waxman/Hatch included thoughtful discussion on the 25-year-old law's more vexing issues, but also some lighthearted recollections. On a panel with FDA Associate Counsel for Drugs Elizabeth Dickinson, Venable LLP partner David Adams noted, "I was sitting in Liz's chair, back when the statute was passed, and we at FDA had to start interpreting and applying this thing. You may or may not be aware there's been much scholarly debate about who is the single attorney responsible for the most judicial losses in the history of FDA - whether it is Liz or whether it was me. Liz argues that although there have been more losses in her lifetime, I'm still responsible for them.
You may also be interested in...
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.